Fulop T, et al. Immunosenescence and altered vaccine efficiency in older subjects: a myth difficult to change. Vaccines. 2022;10(4):607. https://doi.org/10.3390/vaccines10040607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fulop T, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. 2018. https://doi.org/10.3389/fimmu.2017.01960.

Article  PubMed  PubMed Central  Google Scholar 

Aiello A, et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.02247.

Article  PubMed  PubMed Central  Google Scholar 

Van Loveren H, et al. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect. 2001;109(8):757–64. https://doi.org/10.1289/ehp.01109757.

Article  PubMed  PubMed Central  Google Scholar 

Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019. https://doi.org/10.1128/CMR.00084-18.

Article  PubMed  PubMed Central  Google Scholar 

Kwetkat A, Heppner HJ. Comorbidities in the elderly and their possible influence on vaccine response. Interdiscipl Top Gerontol Geriatr. 2020;43:73–85. https://doi.org/10.1159/000504491.

Article  Google Scholar 

Virgilio E, et al. Diabetes affects antibody response to SARS-CoV-2 vaccination in older residents of long-term care facilities: data from the GeroCovid Vax Study. Diabetes Care. 2022;45(12):2935–42. https://doi.org/10.2337/dc22-1255.

Article  CAS  PubMed  Google Scholar 

Agarwal D, Schmader KE, Kossenkov AV, Doyle S, Kurupati R, Ertl HCJ. Immune response to influenza vaccination in the elderly is altered by chronic medication use. Immun Ageing. 2018;15(1):19. https://doi.org/10.1186/s12979-018-0124-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montejano-Hervás P, et al. Safety, Effectiveness, and immunogenicity 6 months after BNT162B2 mRNA vaccine in frail nursing home residents. Drugs Aging. 2022;39(7):587–95. https://doi.org/10.1007/s40266-022-00959-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Villani ER, et al. Relationship between frailty and drug use among nursing homes residents: results from the SHELTER study. Aging Clin Exp Res. 2021;33(10):2839–47. https://doi.org/10.1007/s40520-021-01797-z.

Article  PubMed  Google Scholar 

Palmer K, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10(1):9–36. https://doi.org/10.1007/s41999-018-0124-5.

Article  PubMed  Google Scholar 

Abbatecola AM, et al. Monitoring COVID-19 vaccine use in Italian long term care centers: the GeroCovid VAX study. Vaccine. 2022;40(15):2324. https://doi.org/10.1016/j.vaccine.2022.02.064.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Observational GeroCovid, et al. Disentangling the impact of COVID-19 infection on clinical outcomes and preventive strategies in older persons: an Italian perspective. JGG. 2022;70(1):88–98. https://doi.org/10.36150/2499-6564-N440.

Article  Google Scholar 

Trevisan C, et al. Assessing the impact of COVID-19 on the health of geriatric patients: the European GeroCovid Observational Study. Eur J Intern Med. 2021;87:29–35. https://doi.org/10.1016/j.ejim.2021.01.017.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https://doi.org/10.1186/s12877-017-0621-2.

Article  PubMed  PubMed Central  Google Scholar 

Fedele G, et al. Humoral immunity induced by mRNA COVID-19 vaccines in nursing home residents previously infected with SARS-CoV-2. Aging Clin Exp Res. 2022;34(10):2577–84. https://doi.org/10.1007/s40520-022-02239-0.

Article  PubMed  PubMed Central  Google Scholar 

Granier C, Gey A, Roncelin S, Weiss L, Paillaud E, Tartour E. Immunotherapy in older patients with cancer. Biomed J. 2021;44(3):260–71. https://doi.org/10.1016/j.bj.2020.07.009.

Article  CAS  PubMed  Google Scholar 

Tut G, et al. Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study. Lancet Healthy Longev. 2022;3(7):e461–9. https://doi.org/10.1016/S2666-7568(22)00118-0.

Article  PubMed  PubMed Central  Google Scholar 

Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl. 1):S4-9. https://doi.org/10.1093/gerona/glu057.

Article  PubMed  Google Scholar 

Onder G, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67A(6):698–704. https://doi.org/10.1093/gerona/glr233.

Article  Google Scholar 

Bancos S, Bernard MP, Topham DJ, Phipps RP. Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol. 2009;258(1):18–28. https://doi.org/10.1016/j.cellimm.2009.03.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim H-J, Lee Y-H, Im S-A, Kim K, Lee C-K. Cyclooxygenase inhibitors, aspirin and ibuprofen, inhibit MHC-restricted antigen presentation in dendritic cells. Immune Netw. 2010;10(3):92. https://doi.org/10.4110/in.2010.10.3.92.

Article  PubMed  PubMed Central  Google Scholar 

Omer SB, Phadke VK, Bednarczyk RA, Chamberlain AT, Brosseau JL, Orenstein WA. Impact of statins on influenza vaccine effectiveness against medically attended acute respiratory illness. J Infect Dis. 2016;213(8):1216–23. https://doi.org/10.1093/infdis/jiv457.

Article  PubMed  Google Scholar 

Black S, Nicolay U, Del Giudice G, Rappuoli R. Influence of statins on influenza vaccine response in elderly individuals. J Infect Dis. 2016;213(8):1224–8. https://doi.org/10.1093/infdis/jiv456.

Article  CAS  PubMed  Google Scholar 

Wildes TJ, Grippin A, Fasanya H, Dyson KA, Brantly M. Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: the StatVax randomized clinical tria. Vaccine. 2019;37(10):1313–24. https://doi.org/10.1016/j.vaccine.2019.01.023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giovannini S, Cesari M, Marzetti E, Leeuwenburgh C, Maggio M, Pahor M. Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profil. J Nutr Health Aging. 2010;14(6):457–60. https://doi.org/10.1007/s12603-010-0036-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saum K-U, et al. Is polypharmacy associated with frailty in older people? Results from the ESTHER Cohort Study. J Am Geriatr Soc. 2017;65(2):e27-32. https://doi.org/10.1111/jgs.14718.

Article  PubMed  Google Scholar 

Randles MA, O’Mahony D, Gallagher PF. Frailty and potentially inappropriate prescribing in older people with polypharmacy: a bi-directional relationship? Drugs Aging. 2022;39(8):597–606. https://doi.org/10.1007/s40266-022-00952-z.

Article  PubMed  PubMed Central  Google Scholar 

Giovannini S, et al. Polypharmacy in home care in Europe: cross-sectional data from the IBenC study. Drugs Aging. 2018;35(2):145–52. https://doi.org/10.1007/s40266-018-0521-y.

Article  PubMed  Google Scholar 

Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432–44. https://doi.org/10.1111/bcp.13590.

Article  PubMed  PubMed Central  Google Scholar 

Andrew MK, et al. The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people. J Infect Dis. 2017;216(4):405–14. https://doi.org/10.1093/infdis/jix282.

Article  PubMed  PubMed Central  Google Scholar 

MacIntyre CR, Ridda I, Trent MJ, McIntyre P. Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up. Vaccine. 2019;37(35):5016–24. https://doi.org/10.1016/j.vaccine.2019.07.005.

Article  CAS  PubMed  Google Scholar 

Vetrano DL, et al. Fostering healthy aging: the interdependency of infections, immunity and frailty. Ageing Res Rev. 2021;69: 101351. https://doi.org/10.1016/j.arr.2021.101351.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semelka CT, et al. Frailty and COVID-19 mRNA vaccine antibody response in the COVID-19 Community Research Partnership. J Gerontol A. 2022;77(7):1366–70. https://doi.org/10.1093/gerona/glac095.